Michael, who is AbbVie's president and chief operating officer, will become the company's second-ever CEO on July 1. Gonzalez, who has led the company since it spun out from Abbott Laboratories in ...
AbbVie’s CEO Robert Michael is emerging from his sophomore year at the helm with $32.5 million in 2025 compensation, marking a hefty 75% spike from his first-year pay and solidifying the rising chief ...
What happened? During AbbVie's earnings call, the company provided projections for hepatitis C drug Viekira Pak that disappointed analysts. This underscores how the message from a company's management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results